Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |